515 related articles for article (PubMed ID: 2539153)
1. Calyculin A and okadaic acid: inhibitors of protein phosphatase activity.
Ishihara H; Martin BL; Brautigan DL; Karaki H; Ozaki H; Kato Y; Fusetani N; Watabe S; Hashimoto K; Uemura D
Biochem Biophys Res Commun; 1989 Mar; 159(3):871-7. PubMed ID: 2539153
[TBL] [Abstract][Full Text] [Related]
2. Contrasting effects of calyculin A and okadaic acid on the respiratory burst of human neutrophils.
Djerdjouri B; Combadière C; Pedruzzi E; Hakim J; Périanin A
Eur J Pharmacol; 1995 Jan; 288(2):193-200. PubMed ID: 7720781
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of calyculin A and okadaic acid on the glucose-induced regulation of glycogen synthase and phosphorylase activities in cultured hepatocytes.
Pugazhenthi S; Yu B; Gali RR; Khandelwal RL
Biochim Biophys Acta; 1993 Nov; 1179(3):271-6. PubMed ID: 8218371
[TBL] [Abstract][Full Text] [Related]
4. Regulation of endothelial cell gap formation and barrier function by myosin-associated phosphatase activities.
Verin AD; Patterson CE; Day MA; Garcia JG
Am J Physiol; 1995 Jul; 269(1 Pt 1):L99-108. PubMed ID: 7631821
[TBL] [Abstract][Full Text] [Related]
5. Protein phosphatase inhibitors, okadaic acid and calyculin A, induce alkaline phosphatase activity in osteoblastic cells derived from newborn mouse calvaria.
Murata T; Shirakawa S; Takehara T; Kobayashi S; Haneji T
Biochem Mol Biol Int; 1995 Jun; 36(2):365-72. PubMed ID: 7663440
[TBL] [Abstract][Full Text] [Related]
6. A novel protein phosphatase inhibitor, tautomycin. Effect on smooth muscle.
Hori M; Magae J; Han YG; Hartshorne DJ; Karaki H
FEBS Lett; 1991 Jul; 285(1):145-8. PubMed ID: 1648511
[TBL] [Abstract][Full Text] [Related]
7. The effects of okadaic acid and calyculin A on thrombin induced platelet reaction.
Murata K; Sakon M; Kambayashi J; Yukawa M; Ariyoshi H; Shiba E; Kawasaki T; Kang J; Mori T
Biochem Int; 1992 Feb; 26(2):327-34. PubMed ID: 1313673
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors of protein phosphatase type 1 and 2A attenuate phosphatidylinositol metabolism and Ca(2+)-transients in human platelets. Role of a cdc2-related protein kinase.
Lerea KM
Biochemistry; 1992 Jul; 31(28):6553-61. PubMed ID: 1321663
[TBL] [Abstract][Full Text] [Related]
9. Structurally different members of the okadaic acid class selectively inhibit protein serine/threonine but not tyrosine phosphatase activity.
Suganuma M; Fujiki H; Okabe S; Nishiwaki S; Brautigan D; Ingebritsen TS; Rosner MR
Toxicon; 1992 Aug; 30(8):873-8. PubMed ID: 1326138
[TBL] [Abstract][Full Text] [Related]
10. Multidrug-resistant human KB carcinoma cells are highly resistant to the protein phosphatase inhibitors okadaic acid and calyculin A. Analysis of potential mechanisms involved in toxin resistance.
Chambers TC; Raynor RL; Kuo JF
Int J Cancer; 1993 Jan; 53(2):323-7. PubMed ID: 8093882
[TBL] [Abstract][Full Text] [Related]
11. Calyculin A, an inhibitor of protein phosphatases, a potent tumor promoter on CD-1 mouse skin.
Suganuma M; Fujiki H; Furuya-Suguri H; Yoshizawa S; Yasumoto S; Kato Y; Fusetani N; Sugimura T
Cancer Res; 1990 Jun; 50(12):3521-5. PubMed ID: 2160320
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of an archaeal protein phosphatase activity by okadaic acid, microcystin-LR, or calyculin A.
Oxenrider KA; Rasche ME; Thorsteinsson MV; Kennelly PJ
FEBS Lett; 1993 Oct; 331(3):291-5. PubMed ID: 8397116
[TBL] [Abstract][Full Text] [Related]
13. T cell apoptosis induced by interleukin-2 deprivation or transforming growth factor-beta 2: modulation by the phosphatase inhibitors okadaic acid and calyculin A.
Weller M; Malipiero U; Groscurth P; Fontana A
Exp Cell Res; 1995 Dec; 221(2):395-403. PubMed ID: 7493639
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of protein phosphatases by okadaic acid and calyculin-A differentially modulates hormonal- and forskolin-stimulated formation of cyclic AMP in AtT-20 corticotrophs: effect of pituitary adenylate activating polypeptide and corticotropin-releasing factor.
Koch B; Lutz-Bucher B
Cell Signal; 1994 May; 6(4):467-73. PubMed ID: 7946970
[TBL] [Abstract][Full Text] [Related]
15. Protein phosphatase inhibitors and bone resorption: inhibition by okadaic acid and biphasic actions of calyculin-A.
Goad DL; Meurer EA; Voelkel EF; Petrou CP; Tashjian AH
Endocrinology; 1992 Jun; 130(6):3402-10. PubMed ID: 1375901
[TBL] [Abstract][Full Text] [Related]
16. Calyculin A and okadiac acid inhibit human platelet aggregation by blocking protein phosphatases types 1 and 2A.
Nishikawa M; Toyoda H; Saito M; Morita K; Tawara I; Deguchi K; Kuno T; Shima H; Nagao M; Shirakawa S
Cell Signal; 1994 Jan; 6(1):59-71. PubMed ID: 8011429
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases. Specificity and kinetics.
Bialojan C; Takai A
Biochem J; 1988 Nov; 256(1):283-90. PubMed ID: 2851982
[TBL] [Abstract][Full Text] [Related]
18. Neuronal differentiation of Neuro 2a cells by lactacystin and its partial inhibition by the protein phosphatase inhibitors calyculin A and okadaic acid.
Tanaka H; Katagiri M; Arima S; Matsuzaki K; Inokoshi J; Omura S
Biochem Biophys Res Commun; 1995 Nov; 216(1):291-7. PubMed ID: 7488103
[TBL] [Abstract][Full Text] [Related]
19. The protein phosphatase inhibitor calyculin A stimulates chemokine production by human synovial cells.
Jordan NJ; Watson ML; Westwick J
Biochem J; 1995 Oct; 311 ( Pt 1)(Pt 1):89-95. PubMed ID: 7575485
[TBL] [Abstract][Full Text] [Related]
20. Effects of the protein phosphatase inhibitors okadaic acid and calyculin A on insulin release from rat pancreatic islets.
Tamagawa T; Iguchi A; Uemura K; Miura H; Nonogaki K; Ishiguro T; Sakamoto N
Endocrinol Jpn; 1992 Jun; 39(3):325-9. PubMed ID: 1330503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
